Product
Bach1 Inhibitors
BIOTECHNOLOGY
byIMMvention Therapeutix, Inc.
United States (US)
ABOUT THE PRODUCT
Development of orally available small molecule inhibitors targeting Bach1, a key transcription factor involved in various disease pathways.
Information is owner-confirmed
Last updated 2 months ago
Price range